MNPR Competitors & Alternatives
Compare Monopar Therapeutics Inc with similar stocks in the same industry
Biotechnology
MNPR
Main Stock$103.41
Tradestie Score
56
Market Cap
$522.78M
Analyst Upside
+9.9%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVBP
ArriVent BioPharma, Inc. Common Stock
|
$32.64
|
$748.90M | - | 59 | Compare |
|
TBPH
Theravance Biopharma, Inc.
|
$16.95
|
$726.21M | 7.6 | 57 | Compare |
|
NRIX
Nurix Therapeutics, Inc. Common stock
|
$23.66
|
$718.62M | - | 61 | Compare |
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$31.80
|
$715.25M | - | 64 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$152.69
|
$699.30M | - | 60 | Compare |
|
GYRE
Gyre Therapeutics, Inc. Common Stock
|
$6.59
|
$688.47M | - | 56 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
ARVN
Arvinas, Inc
|
$8.30
|
$670.30M | - | 54 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$12.58
|
$665.30M | - | 61 | Compare |
More MNPR Analysis
Data updated: Jul 15, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry